Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

 

Nonmalignant Hematology
06:25

Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

DVT/PE: Full-Dose or Intermediate-Dose DOAC?

FEATURING Stephan Moll
  • 157 views
  • December 17, 2020
  • 1
13:54

Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

DVT/PE: What is the Optimal Duration of Anticoagulation with DOACs like Rivaroxaban and Apixiban?

FEATURING Stephan Moll
  • 293 views
  • December 17, 2020
  • 1
11:29

Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

Oral Anticoagulant Therapy: How Can We Improve on Existing Oral Anticoagulant Drugs?

FEATURING John Eikelboom
  • 117 views
  • December 17, 2020
10:02

Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

Oral Anticoagulant Therapy: What are the Unmet Needs?

FEATURING John Eikelboom
  • 115 views
  • December 17, 2020
25:59

Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

Approach to Thrombocytopenia in the Hospitalized Patient

FEATURING John Kelton
  • 247 views
  • March 16, 2020
  • 2
17:54

Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

Key Concept of Heparin-induced Thrombocytopenia in 2020: Approach & Treatment

FEATURING John Kelton
  • 150 views
  • March 16, 2020
  • 1
21:26

Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

Case of 54/m With Thrombotic Microangiopathy: Differentiating TTP and aHUS, Ravulizumab for aHUS / Case of 27/F With aHUS: Approach to Eculizumab Discontinuation and Monitoring

FEATURING Shruti Chaturvedi
  • 168 views
  • March 16, 2020
  • 2
14:03

Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

Role of Complement Activation in HELLP and CAPS & Complement in Cold Agglutinin Disease

FEATURING Shruti Chaturvedi
  • 198 views
  • March 16, 2020
  • 1
20:32

Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

Algorithms to Minimize Bleeding in At Risk Patient Populations on Anticoagulation

FEATURING Jennifer Green
  • 1,547 views
  • March 16, 2020
  • 11
10:10

Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

Considerations on Oral Anticoagulant Use After Bariatric Surgery & Laboratory Assessment of Anticoagulants In Bleeding Patients

FEATURING Jennifer Green
  • 36 views
  • March 16, 2020
24:44

Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

Diagnosis of Waldenstrom Macroglobulinemia: MYD88 Mutation Status, International Staging System, Hyperviscosity Therapy, and Kidney Manifestations

FEATURING Morie Gertz
  • 162 views
  • March 16, 2020
18:52

Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

Treatment of Waldenstrom Macroglobulinemia: Bendamustine Based Therapies, Rituximab Maintenance, Ibrutinib Efficacy, Venetoclax in RRWM

FEATURING Morie Gertz
  • 1,108 views
  • March 16, 2020
  • 7
36:18

Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

Understand Principles of Diagnosing Von Willebrand Disease and Its Subtypes

FEATURING Alice Ma
  • 185 views
  • March 16, 2020
  • 2
07:08

Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

Difficulties in Testing for Von Willebrand Disease & Treatment Options

FEATURING Alice Ma
  • 358 views
  • March 16, 2020
  • 2
05:55

Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

VTE in Cancer: Risk Factors, DOACS are Reasonable Choice, Less Recurrent VTE with Apixaban

FEATURING Stephan Moll
  • 941 views
  • March 16, 2020
  • 4
20:20

Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

DVT/PE: Duration of Anticoagulation, Full-Dose or Intermediate-Dose DOAC? & Is LA Reliable on DOAC?

FEATURING Stephan Moll
  • 3,187 views
  • March 16, 2020
  • 15
13:35

Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

DOAC Update: Use in Obese Pts, DOAC vs VKA, APS and DOACs

FEATURING Stephan Moll
  • 63 views
  • March 16, 2020
05:33

Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

54 y/o Man on Long-term Rivaroxaban Needs Screening Colonoscopy: When to Stop DOAC?

FEATURING Stephan Moll
  • 57 views
  • March 16, 2020
17:39

Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

Challenges of Anticoagulant Selection, Dosing, and Administration in Critically Ill Patients

FEATURING Menaka Pai
  • 27 views
  • March 18, 2020
14:36

Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

Monitoring, Interrupting, Reversing Anticoagulants, Management of DOAC Related Bleeding & Unique Challenges in the ICU

FEATURING Menaka Pai
  • 47 views
  • March 18, 2020
23:45

Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

Oral Anticoagulant Therapy: Unmet Needs & Improving on Existing Oral Anticoagulant Drugs

FEATURING John Eikelboom
  • 233 views
  • March 18, 2020
  • 2
11:34

Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

Are There Ways Other Than Directly Targeting Coagulation to Reduce the Burden of Thromboembolism?

FEATURING John Eikelboom
  • 798 views
  • March 18, 2020
  • 5